NDC Pharmacologic Class A-Z Index

Pharmacologic Code	Pharmacologic Name	Pharmacologic Class	Count
N0000000126	5-alpha Reductase Inhibitors	[MoA]	99
N0000175955	5-Lipoxygenase Inhibitors	[MoA]	4
N0000000183	Acetyl Aldehyde Dehydrogenase Inhibitors	[MoA]	14
N0000175770	Acetylcholine Release Inhibitors	[MoA]	18
N0000175833	Acidifying Activity	[MoA]	216
N0000175788	Adenosine Receptor Agonists	[MoA]	38
N0000175921	Adrenal Steroid Synthesis Inhibitors	[MoA]	1
N0000000122	Adrenergic Agonists	[MoA]	7
N0000009917	Adrenergic alpha1-Agonists	[MoA]	36
N0000009918	Adrenergic alpha2-Agonists	[MoA]	473
N0000000209	Adrenergic alpha-Agonists	[MoA]	287
N0000000099	Adrenergic alpha-Antagonists	[MoA]	629
N0000009923	Adrenergic beta1-Antagonists	[MoA]	263
N0000009922	Adrenergic beta2-Agonists	[MoA]	221
N0000009924	Adrenergic beta2-Antagonists	[MoA]	263
N0000185007	Adrenergic beta3-Agonists	[MoA]	4
N0000000245	Adrenergic beta-Agonists	[MoA]	219
N0000000161	Adrenergic beta-Antagonists	[MoA]	1350
N0000011310	Aldosterone Antagonists	[MoA]	162
N0000000236	Alkylating Activity	[MoA]	190
N0000000166	alpha Glucosidase Inhibitors	[MoA]	36
N0000187052	alpha-Particle Emitting Activity	[MoA]	1
N0000175806	Ammonium Ion Binding Activity	[MoA]	45
N0000020016	AMPA Receptor Antagonists	[MoA]	7
N0000020064	Amylin Agonists	[MoA]	2
N0000000146	Androgen Receptor Agonists	[MoA]	91
N0000000243	Androgen Receptor Antagonists	[MoA]	23
N0000000070	Angiotensin 2 Receptor Antagonists	[MoA]	1288
N0000180999	Angiotensin 2 Type 1 Receptor Antagonists	[MoA]	4
N0000000181	Angiotensin-converting Enzyme Inhibitors	[MoA]	1505
N0000192702	Anthrax Protective Antigen-directed Antibody Interactions	[MoA]	3
N0000020023	Antibody-Surface Protein Interactions	[MoA]	2
N0000184008	Antigen Neutralization	[MoA]	37
N0000175080	Aromatase Inhibitors	[MoA]	60
N0000182636	B Lymphocyte Stimulator-directed Antibody Interactions	[MoA]	3
N0000184141	Bacterial Neurotoxin Neutralization	[MoA]	1
N0000000202	beta Lactamase Inhibitors	[MoA]	351
N0000175365	Bile-acid Binding Activity	[MoA]	38
N0000182964	Bradykinin B2 Receptor Antagonists	[MoA]	1
N0000190113	Breast Cancer Resistance Protein Inhibitors	[MoA]	71
N0000175458	Calcineurin Inhibitors	[MoA]	111
N0000000069	Calcium Channel Antagonists	[MoA]	1446
N0000175089	Calcium Chelating Activity	[MoA]	185
N0000184143	Carbamoyl Phosphate Synthetase 1 Activators	[MoA]	1
N0000000235	Carbonic Anhydrase Inhibitors	[MoA]	131
N0000175756	Catechol O-Methyltransferase Inhibitors	[MoA]	59
N0000175361	Catecholamine Synthesis Inhibitors	[MoA]	1
N0000175078	CD20-directed Antibody Interactions	[MoA]	8
N0000193616	CD22-directed Antibody Interactions	[MoA]	1
N0000182966	CD30-directed Antibody Interactions	[MoA]	1
N0000175077	CD33-directed Antibody Interactions	[MoA]	1
N0000192335	CD38-directed Antibody Interactions	[MoA]	1
N0000175079	CD52-directed Antibody Interactions	[MoA]	2
N0000182150	CD80-directed Antibody Interactions	[MoA]	1
N0000182151	CD86-directed Antibody Interactions	[MoA]	1
N0000000087	Chelating Activity	[MoA]	3
N0000175445	Chemokine Co-receptor 5 Antagonists	[MoA]	8
N0000184145	Chloride Channel Activation Potentiators	[MoA]	7
N0000175456	Chloride Channel Activators	[MoA]	5
N0000175369	Cholinergic Agonists	[MoA]	27
N0000175370	Cholinergic Antagonists	[MoA]	550
N0000000104	Cholinergic Muscarinic Agonists	[MoA]	83
N0000000125	Cholinergic Muscarinic Antagonists	[MoA]	342
N0000000177	Cholinesterase Inhibitors	[MoA]	332
N0000000080	Cholinesterase Reactivators	[MoA]	2
N0000175686	Competitive Opioid Antagonists	[MoA]	23
N0000175974	Complement Inhibitors	[MoA]	1
N0000175450	Corticosteroid Hormone Receptor Agonists	[MoA]	1646
N0000182634	CTLA-4-directed Antibody Interactions	[MoA]	2
N0000000160	Cyclooxygenase Inhibitors	[MoA]	2103
N0000175549	Cystine Disulfide Reduction	[MoA]	8
N0000182632	Cytochrome P450 17A1 Inhibitors	[MoA]	5
N0000191624	Cytochrome P450 1A Inducers	[MoA]	7
N0000191266	Cytochrome P450 1A2 Inducers	[MoA]	223
N0000182138	Cytochrome P450 1A2 Inhibitors	[MoA]	79
N0000187064	Cytochrome P450 2B6 Inducers	[MoA]	281
N0000182139	Cytochrome P450 2B6 Inhibitors	[MoA]	2
N0000185607	Cytochrome P450 2C19 Inducers	[MoA]	232
N0000182140	Cytochrome P450 2C19 Inhibitors	[MoA]	865
N0000187063	Cytochrome P450 2C8 Inducers	[MoA]	106
N0000187062	Cytochrome P450 2C8 Inhibitors	[MoA]	367
N0000185507	Cytochrome P450 2C9 Inducers	[MoA]	258
N0000185504	Cytochrome P450 2C9 Inhibitors	[MoA]	505
N0000191267	Cytochrome P450 2D6 Inducers	[MoA]	102
N0000182137	Cytochrome P450 2D6 Inhibitors	[MoA]	264
N0000190118	Cytochrome P450 3A Inducers	[MoA]	196
N0000190114	Cytochrome P450 3A Inhibitors	[MoA]	382
N0000185506	Cytochrome P450 3A4 Inducers	[MoA]	394
N0000182141	Cytochrome P450 3A4 Inhibitors	[MoA]	836
N0000190115	Cytochrome P450 3A5 Inhibitors	[MoA]	60
N0000175844	Decarboxylase Inhibitors	[MoA]	1
N0000175532	Demulcent Activity	[MoA]	1
N0000184150	Digoxin Binding Activity	[MoA]	1
N0000000191	Dihydrofolate Reductase Inhibitors	[MoA]	218
N0000185501	Dihydroorotate Dehydrogenase Inhibitors	[MoA]	4
N0000175513	Dipeptidase Inhibitors	[MoA]	9
N0000175912	Dipeptidyl Peptidase 4 Inhibitors	[MoA]	55
N0000020060	DNA Polymerase Inhibitors	[MoA]	429
N0000193801	DNA Terminase Complex Inhibitors	[MoA]	4
N0000175755	DOPA Decarboxylase Inhibitors	[MoA]	6
N0000000117	Dopamine Agonists	[MoA]	362
N0000175799	Dopamine D2 Antagonists	[MoA]	103
N0000000114	Dopamine Uptake Inhibitors	[MoA]	358
N0000175533	Dyes	[MoA]	19
N0000184012	Endogenous Antigen Neutralization	[MoA]	5
N0000175364	Endothelin Receptor Antagonists	[MoA]	8
N0000192345	Epoxide Hydrolase Inhibitors	[MoA]	7
N0000000100	Estrogen Receptor Agonists	[MoA]	246
N0000000145	Estrogen Receptor Antagonists	[MoA]	1
N0000175635	Factor Xa Inhibitors	[MoA]	44
N0000192560	Farnesoid X Receptor Agonists	[MoA]	2
N0000000111	Folic Acid Metabolism Inhibitors	[MoA]	67
N0000000170	Free Radical Scavenging Activity	[MoA]	2
N0000175684	Full Opioid Agonists	[MoA]	1542
N0000175615	Fusion Protein Inhibitors	[MoA]	2
N0000000196	GABA A Agonists	[MoA]	342
N0000000116	GABA B Agonists	[MoA]	120
N0000020058	Glucagon-like Peptide-1 (GLP-1) Agonists	[MoA]	17
N0000190990	Glucagon-like Peptide-2 (GLP-2) Agonists	[MoA]	1
N0000020019	Glucosylceramide Synthase Inhibitors	[MoA]	4
N0000191499	Glycolipid Disialoganglioside-directed Antibody Interactions	[MoA]	1
N0000175654	Gonadotropin Releasing Hormone Receptor Agonists	[MoA]	8
N0000175084	Gonadotropin Releasing Hormone Receptor Antagonists	[MoA]	1
N0000193786	Growth Hormone Secretagogue Receptor Agonists	[MoA]	1
N0000185499	Guanylate Cyclase Activators	[MoA]	5
N0000190484	Guanylate Cyclase Stimulators	[MoA]	5
N0000182638	HCV NS3/4A Protease Inhibitors	[MoA]	3
N0000175981	Heparin Binding Activity	[MoA]	3
N0000020010	HER1 Antagonists	[MoA]	5
N0000020008	HER2/Neu/cerbB2 Antagonists	[MoA]	2
N0000000190	Histamine H1 Receptor Antagonists	[MoA]	211
N0000000151	Histamine H2 Receptor Antagonists	[MoA]	345
N0000000207	Histamine Receptor Antagonists	[MoA]	361
N0000175071	Histone Deacetylase Inhibitors	[MoA]	5
N0000000127	HIV Integrase Inhibitors	[MoA]	26
N0000000246	HIV Protease Inhibitors	[MoA]	97
N0000000121	Hydroxymethylglutaryl-CoA Reductase Inhibitors	[MoA]	1292
N0000175808	Hydroxyphenylpyruvate Dioxygenase Inhibitors	[MoA]	8
N0000191546	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists	[MoA]	2
N0000175792	IgE-directed Antibody Interactions	[MoA]	3
N0000020081	Increased Calcium-sensing Receptor Sensitivity	[MoA]	19
N0000175774	Integrin Receptor Antagonists	[MoA]	2
N0000000157	Interferon Inducers	[MoA]	11
N0000175709	Interleukin 1 Receptor Antagonists	[MoA]	1
N0000193279	Interleukin 17 Receptor A Antagonists	[MoA]	1
N0000010279	Interleukin 2 Receptor Antagonists	[MoA]	4
N0000175621	Interleukin 2 Receptor-directed Antibody Interactions	[MoA]	4
N0000193341	Interleukin 4 Receptor alpha Antagonists	[MoA]	3
N0000193802	Interleukin 5 Receptor alpha-directed Antibody Interactions	[MoA]	1
N0000190478	Interleukin 6 Receptor Antagonists	[MoA]	8
N0000192796	Interleukin-12 Antagonists	[MoA]	3
N0000191494	Interleukin-17A Antagonists	[MoA]	3
N0000192798	Interleukin-23 Antagonists	[MoA]	5
N0000191871	Interleukin-5 Antagonists	[MoA]	2
N0000191004	Interleukin-6 Antagonists	[MoA]	2
N0000175356	Ion Exchange Activity	[MoA]	1
N0000000144	Iron Chelating Activity	[MoA]	24
N0000175534	Irrigation	[MoA]	1
N0000193614	Isocitrate Dehydrogenase 2 Inhibitors	[MoA]	2
N0000190857	Janus Kinase Inhibitors	[MoA]	6
N0000184151	Kallikrein Inhibitors	[MoA]	2
N0000175082	Kinase Inhibitors	[MoA]	19
N0000175962	Lead Chelating Activity	[MoA]	6
N0000000083	Leukotriene Receptor Antagonists	[MoA]	173
N0000009916	Lipase Inhibitors	[MoA]	2
N0000192700	Lymphocyte Function-Associated Antigen-1 Antagonists	[MoA]	1
N0000175542	M2 Protein Inhibitors	[MoA]	61
N0000175834	Magnesium Ion Exchange Activity	[MoA]	202
N0000175862	Magnetic Resonance Contrast Activity	[MoA]	28
N0000175850	Melanin Synthesis Inhibitors	[MoA]	46
N0000000250	Melatonin Receptor Agonists	[MoA]	5
N0000175472	Metal Chelating Activity	[MoA]	4
N0000175804	Methylating Activity	[MoA]	6
N0000186778	Microsomal Triglyceride Transfer Protein Inhibitors	[MoA]	6
N0000000184	Monoamine Oxidase Inhibitors	[MoA]	36
N0000175761	Monoamine Oxidase-B Inhibitors	[MoA]	15
N0000175624	mTOR Inhibitors	[MoA]	25
N0000191423	Multidrug and Toxin Extrusion Transporter 1 Inhibitors	[MoA]	6
N0000020069	N-Calcium Channel Receptor Antagonists	[MoA]	6
N0000191727	Neprilysin Inhibitors	[MoA]	3
N0000175436	Neuraminidase Inhibitors	[MoA]	6
N0000010262	Neurokinin 1 Antagonists	[MoA]	17
N0000020015	NMDA Receptor Antagonists	[MoA]	129
N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	[MoA]	67
N0000000102	Norepinephrine Uptake Inhibitors	[MoA]	1068
N0000000233	Nucleic Acid Synthesis Inhibitors	[MoA]	248
N0000009947	Nucleoside Reverse Transcriptase Inhibitors	[MoA]	404
N0000000174	Opioid Agonists	[MoA]	470
N0000000154	Opioid Antagonists	[MoA]	131
N0000191866	Opioid mu-Receptor Agonists	[MoA]	2
N0000190998	Orexin Receptor Antagonists	[MoA]	4
N0000190110	Organic Anion Transporter 1 Inhibitors	[MoA]	2
N0000190111	Organic Anion Transporter 3 Inhibitors	[MoA]	2
N0000190107	Organic Anion Transporting Polypeptide 1B1 Inhibitors	[MoA]	46
N0000190108	Organic Anion Transporting Polypeptide 1B3 Inhibitors	[MoA]	26
N0000190109	Organic Anion Transporting Polypeptide 2B1 Inhibitors	[MoA]	2
N0000191265	Organic Cation Transporter 1 Inhibitors	[MoA]	2
N0000187061	Organic Cation Transporter 2 Inhibitors	[MoA]	203
N0000010288	Osmotic Activity	[MoA]	1173
N0000175545	Oxidation-Reduction Activity	[MoA]	21
N0000182143	P2Y12 Receptor Antagonists	[MoA]	130
N0000175702	Partial Cholinergic Nicotinic Agonists	[MoA]	9
N0000175685	Partial Opioid Agonists	[MoA]	147
N0000191730	PCSK9 Inhibitors	[MoA]	8
N0000175374	Peroxisome Proliferator-activated Receptor Activity	[MoA]	135
N0000175375	Peroxisome Proliferator-activated Receptor alpha Agonists	[MoA]	96
N0000191264	P-Glycoprotein Inducers	[MoA]	9
N0000185503	P-Glycoprotein Inhibitors	[MoA]	618
N0000000239	P-Glycoprotein Interactions	[MoA]	26
N0000190482	Phenylalanine Hydroxylase Activators	[MoA]	6
N0000020074	Phosphate Chelating Activity	[MoA]	107
N0000175086	Phosphodiesterase 3 Inhibitors	[MoA]	46
N0000182960	Phosphodiesterase 4 Inhibitors	[MoA]	6
N0000020026	Phosphodiesterase 5 Inhibitors	[MoA]	180
N0000010217	Photoabsorption	[MoA]	8
N0000191622	Poly(ADP-Ribose) Polymerase Inhibitors	[MoA]	7
N0000175869	Positron Emitting Activity	[MoA]	3
N0000175448	Potassium Channel Antagonists	[MoA]	63
N0000182728	Potassium Channel Openers	[MoA]	3
N0000178377	Potassium Ion Binding Activity	[MoA]	3
N0000000115	Progestational Hormone Receptor Antagonists	[MoA]	1
N0000193337	Programmed Death Ligand-1 Antagonists	[MoA]	3
N0000193336	Programmed Death Ligand-1-directed Antibody Interactions	[MoA]	3
N0000191259	Programmed Death Receptor-1-directed Antibody Interactions	[MoA]	6
N0000020068	Prostacyclin Receptor Agonists	[MoA]	8
N0000000106	Prostaglandin Receptor Agonists	[MoA]	16
N0000190995	Protease-activated Receptor-1 Antagonists	[MoA]	1
N0000175075	Proteasome Inhibitors	[MoA]	8
N0000175076	Protein Kinase Inhibitors	[MoA]	111
N0000000150	Protein Synthesis Inhibitors	[MoA]	46
N0000000147	Proton Pump Inhibitors	[MoA]	620
N0000000205	Radiopharmaceutical Activity	[MoA]	114
N0000187054	RANK Ligand Blocking Activity	[MoA]	2
N0000020000	Receptor Tyrosine Kinase Inhibitors	[MoA]	12
N0000175547	Reduction Activity	[MoA]	25
N0000175899	Renin Inhibitors	[MoA]	7
N0000193789	Rho Kinase Inhibitors	[MoA]	1
N0000191258	RNA Replicase Inhibitors	[MoA]	4
N0000175516	RNA Synthetase Inhibitors	[MoA]	45
N0000020024	Sclerosing Activity	[MoA]	3
N0000000168	Selective Estrogen Receptor Modulators	[MoA]	63
N0000191262	Selective Progesterone Receptor Modulators	[MoA]	3
N0000175763	Serotonin 1b Receptor Agonists	[MoA]	299
N0000175764	Serotonin 1d Receptor Agonists	[MoA]	299
N0000185009	Serotonin 2c Receptor Agonists	[MoA]	2
N0000175817	Serotonin 3 Receptor Antagonists	[MoA]	384
N0000000109	Serotonin Uptake Inhibitors	[MoA]	1808
N0000182147	Sigma-1 Receptor Agonists	[MoA]	29
N0000192337	SLAMF7-directed Antibody Interactions	[MoA]	2
N0000184148	Smoothened Receptor Antagonists	[MoA]	2
N0000187058	Sodium-Glucose Transporter 2 Inhibitors	[MoA]	39
N0000000194	Somatostatin Receptor Agonists	[MoA]	52
N0000181815	Sphingosine 1-Phosphate Receptor Modulators	[MoA]	2
N0000000079	Surfactant Activity	[MoA]	3
N0000009963	Thrombin Inhibitors	[MoA]	31
N0000175968	Thrombopoietin Receptor Agonists	[MoA]	11
N0000191869	Thymidine Phosphorylase Inhibitors	[MoA]	2
N0000175917	Thyroid Hormone Synthesis Inhibitors	[MoA]	44
N0000000176	Topoisomerase Inhibitors	[MoA]	141
N0000000197	Trypsin Inhibitors	[MoA]	2
N0000193302	Tryptophan Hydroxylase Inhibitors	[MoA]	1
N0000175451	Tumor Necrosis Factor Receptor Blocking Activity	[MoA]	14
N0000020001	Tyrosine Kinase Inhibitors	[MoA]	6
N0000190117	UDP Glucuronosyltransferases Inducers	[MoA]	25
N0000191269	UDP Glucuronosyltransferases Inhibitors	[MoA]	30
N0000191272	UGT1A1 Inhibitors	[MoA]	41
N0000191275	UGT1A3 Inhibitors	[MoA]	9
N0000191276	UGT1A4 Inhibitors	[MoA]	9
N0000191277	UGT1A6 Inhibitors	[MoA]	9
N0000191278	UGT1A9 Inhibitors	[MoA]	9
N0000191274	UGT2B15 Inhibitors	[MoA]	9
N0000191273	UGT2B7 Inhibitors	[MoA]	9
N0000010259	Ultrasound Contrast Activity	[MoA]	3
N0000181819	Uncompetitive NMDA Receptor Antagonists	[MoA]	29
N0000192340	Urate Transporter 1 Inhibitors	[MoA]	4
N0000175087	Urease Inhibitors	[MoA]	1
N0000193542	Vascular Endothelial Growth Factor Inhibitors	[MoA]	9
N0000178291	Vascular Endothelial Growth Factor-directed Antibody Interactions	[MoA]	4
N0000020044	Vasopressin Receptor Antagonists	[MoA]	1
N0000193178	Vasopressin V2 Receptor Antagonists	[MoA]	4
N0000020032	VEGFR2 Inhibitors	[MoA]	2
N0000184010	Venom Neutralization	[MoA]	5
N0000190855	Vesicular Monoamine Transporter 2 Inhibitors	[MoA]	22
N0000184009	Virus Neutralization	[MoA]	13
N0000175964	Vitamin K Inhibitors	[MoA]	243
N0000000206	Xanthine Oxidase Inhibitors	[MoA]	139
N0000010258	X-Ray Contrast Activity	[MoA]	170